|
COPG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.217700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.745000E-01 |
| Normal-vs-Stage2 |
5.966600E-01 |
| Normal-vs-Stage3 |
3.536500E-03 |
| Normal-vs-Stage4 |
6.382400E-01 |
| Stage1-vs-Stage2 |
5.107400E-01 |
| Stage1-vs-Stage3 |
5.593200E-04 |
| Stage1-vs-Stage4 |
6.131200E-01 |
| Stage2-vs-Stage3 |
6.793900E-02 |
| Stage2-vs-Stage4 |
7.497400E-01 |
| Stage3-vs-Stage4 |
7.298200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.709600E-02 |
| Normal-vs-AfricanAmerican |
7.797800E-01 |
| Normal-vs-Asian |
4.268800E-01 |
| Caucasian-vs-AfricanAmerican |
2.465000E-01 |
| Caucasian-vs-Asian |
6.044000E-01 |
| AfricanAmerican-vs-Asian |
2.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.268800E-01 |
| Normal-vs-Female |
1.603610E-03 |
| Male-vs-Female |
4.364800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.627800E-01 |
| Normal-vs-Extreme_Weight |
9.535800E-01 |
| Normal-vs-Obese |
1.133390E-01 |
| Normal-vs-Extreme_Obese |
6.928600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.701400E-01 |
| Normal_Weight-vs-Obese |
9.902200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.518800E-01 |
| Extreme_Weight-vs-Obese |
1.534760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.195600E-01 |
| Obese-vs-Extreme_Obese |
2.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.658200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.276200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.579800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.172800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.487400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.500200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.508400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.330010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.226800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.390800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.326400E-01 |
| Normal-VS-Type2 PRCC |
3.432000E-01 |
| Normal-VS-KIRP CIMP |
1.240240E-01 |
| Normal-VS-Unclassified PRCC |
4.245500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.207800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.492560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.018030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.604590E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.013200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.647600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.316000E-01 |
| Normal-vs-N1 |
1.350450E-02 |
| Normal-vs-N2 |
5.148600E-01 |
| N0-vs-N1 |
2.730200E-02 |
| N0-vs-N2 |
5.396600E-01 |
| N1-vs-N2 |
7.096800E-01 |
|
|
